Skip to main content
Fig. 3 | Translational Neurodegeneration

Fig. 3

From: Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer’s disease: a systematic review and meta-analysis

Fig. 3

Comparison of plasma tau or ptau181 between AD and healthy controls. Meta-analysis of studies comparing plasma tau (a) and ptau181 (b) levels between AD and healthy controls, detected by the Simoa method. In ptau181 studies, the study of O’connor et al. was a familial AD study; the average age in the study of Rodriguez et al. was considerably higher; the control cohort used in the study of Suarez-Calvet et al. comprised ‘middle-aged’ adults; the TRIAD cohort in Karikari et al. included young individuals, all of which may have contributed to the heterogeneity. AD, Alzheimer’s disease; SD, standard deviation; CI, confidence interval; WMD, weighted mean difference

Back to article page